Keyphrases
Post-stroke Fatigue
100%
Standardized Mean Difference
40%
Confidence Interval
30%
Review Authors
30%
Randomized Controlled Trial
20%
Fatigue Severity Scale
20%
People with Stroke
20%
Non-pharmaceutical Interventions
20%
Risk of Bias
20%
Control Arm
20%
Meta-analysis
10%
Nursing
10%
Disability
10%
CINAHL
10%
MEDLINE
10%
Embase
10%
High Risk
10%
Absence of Evidence
10%
Cochrane
10%
Inclusion Criteria
10%
Beneficial Effects
10%
Intervention Group
10%
Health-related Quality of Life
10%
Quality of Death
10%
PsycINFO
10%
Cochrane Library
10%
Cochrane Central Register of Controlled Trials
10%
Extracted Data
10%
AMED
10%
Sensitivity Analysis
10%
Intervention Effect
10%
Education Program
10%
Separation Analysis
10%
Methodological Quality
10%
Subgroup Analysis
10%
Dichotomous Outcomes
10%
Risk Ratio
10%
Search Methods
10%
Continuous Positive Airway Pressure
10%
Self-management Program
10%
PEDro
10%
Issue 4
10%
Chronic Disease
10%
Selection Criteria
10%
Pharmacological Intervention
10%
Allocation Concealment
10%
Ongoing Trials
10%
Random Effects Model
10%
Fluoxetine
10%
Antidepressants
10%
Mindfulness-based Stress Reduction
10%
Sleep Apnea
10%
Active Intervention
10%
Citicoline
10%
Citation Tracking
10%
Tirilazad
10%
Mesylate
10%
Chinese Herbs
10%
Degrees of Freedom
10%
OSU6162
10%
I2 Statistic
10%
Trial Registries
10%
Rational Basis
10%
Adequate Sample Size
10%
Continuous Outcomes
10%
Nursing and Health Professions
Cerebrovascular Accident
100%
Confidence Interval
18%
Cochrane Library
12%
CINAHL
6%
Self Care
6%
Sample Size
6%
Chronic Disease
6%
Quality of Life
6%
Meta Analysis
6%
PsycINFO
6%
British Nursing Index
6%
Effect Size
6%
Sleep Disordered Breathing
6%
Continuous Positive Airway Pressure
6%
PEDro
6%
Tirilazad
6%
Fluoxetine
6%
Citicoline
6%
3 [3 (Methylsulfonyl)phenyl] 1 Propylpiperidine
6%
Mindfulness-Based Stress Reduction
6%
Antidepressant
6%
Medicine and Dentistry
Apoplexy
100%
Randomized Controlled Trial
12%
Arm
12%
Meta-Analysis
6%
Quality of Life
6%
Health Care Cost
6%
Effect Size
6%
Subgroup Analysis
6%
Obstructive Sleep Apnea
6%
Continuous Positive Airway Pressure
6%
Chronic Disease
6%
Group Trial
6%
Random Effects Model
6%
Citicoline
6%
Fluoxetine
6%
Mindfulness-Based Stress Reduction
6%
3 [3 (Methylsulfonyl)phenyl] 1 Propylpiperidine
6%
Chinese Herb
6%
Tirilazad
6%
Antidepressant
6%
Neuroscience
Cerebrovascular Accident
100%
Randomized Controlled Trial
12%
Meta-Analysis
6%
Antidepressant
6%
Citicoline
6%
Fluoxetine
6%
Mindfulness
6%
Obstructive Sleep Apnea
6%